As part of the "Eternal Saga" autumn season, Warface is launching an exciting event called "Patient Zero" with the introduction of a new PvP mode and stunning rewards inspired by Scandinavian mysticism.
Well-known publisher and developer Astrum Entertainment is pleased to present an update for the tactical shooter Warface. As part of the Patient Zero event, players will be able to plunge into a new PvP mode called Infection, where allies must identify and stop the traitor. At the start of the match, all players are in a group of survivors, but one of them becomes Patient Zero and turns into a zombie. The task of the rest is to survive at any cost and not go over to the side of the infected. Match participants also have the opportunity to earn personal points, which affect the rewards they receive. Among them you can find weapons from the Helheim and Ragnarok series, as well as an ominous mask and gloves.
In addition, the "Sinister Hunt" promotion is available for players on a special page dedicated to Halloween. Participants will receive a pack that includes skins and weapons for one of four classes: Assault, Medic, Engineer or Sniper, depending on their class preferences.
This update is available on the VK Play platform and will last until November 8.
In addition, the kibe continuessports tournament Warface PRO.Fall 2023 with a prize fund of 6,700,000 rubles. The autumn season of the 2023 Warface PRO championship consists of 5 stages: Challengers, Masters, Champions, Legends and Valkyries (women's professional league with a prize fund of 500,000 rubles). The LAN finals of the tournament will be held in Moscow on November 18 and 19.
Reynolds fought the reporters as best he could.
We will also be shown new gameplay.
There is little information, so the shooter could be based on the StarCraft, Warcraft universe, or a completely new IP.
On the evening of November 14, 2024, Obsidian began accepting pre-orders for its new RPG Avowed on all major platforms, including the Russian Steam.
The project is codenamed Half-Life X.